title: FDA proposes higher fees for drug approvals to cover postmarketing surveillance.
authors.forename: Janice Hopkins
authors.initials: JH
authors.lastname: Tanne
mesh_terms: D017277:Drug Approval / Q000191:economics*; D005249:Fees and Charges; D011358:Product Surveillance, Postmarketing / Q000191:economics*; D014481:United States; D014486:United States Food and Drug Administration